Document is current

Article History

Received: 4 April 2017

Accepted: 24 July 2017

First Online: 21 August 2017

Competing Interests

: Dr. Ferrer is a member of the scientific advisory board of Novartis, is a speaker for both Novartis and FAES, has served on the scientific advisory board of Genen-tech, receives research grants from Novartis and has received the speaker honorarium title from MSD, Novartis, FAES and GSK. Antonio Valero reports having worked as a consultant for Faes Farma, Chiesi, Orion Pharma, MSD, Novartis, UCB, Uriach Pharma, GSK and Stallergenes; having been paid lecture fees by Novartis, GSK, Stallergenes, Chiesi, Leti and Thermofisher; and having received grant support from Novartis, Faes Farma and Uriach Pharma. Joan Bartra reports having served as a consultant for Novartis, Faes Farma and Hal Allergy and having been paid lecture fees by Novartis, Stallergenes, UCB, Thermofisher, Menarini and Chiesi.